Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a sele…
Biotechnology
US, San Francisco [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Olema Pharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
Olema Pharmaceuticals, Inc. has no acquisition track records yet.